Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)

Rhea-AI Summary

Definitive Healthcare (Nasdaq: DH), a healthcare commercial intelligence company, announced inducement grants for two newly hired senior executives. The company's Human Capital Management and Compensation Committee has awarded 421,349 time-based restricted stock units (RSUs) each to Jeannine Lombardi, the new Chief Human Resource Officer, and Jonathan Paris, the new Chief Legal Officer.

The RSUs were granted on July 1, 2025, under Nasdaq Listing Rule 5635(c)(4) and Definitive Healthcare's 2023 Inducement Plan. The vesting schedule includes 25% vesting on July 1, 2026, followed by quarterly installments of 6.25% over the subsequent three years, subject to continued employment.

FRAMINGHAM, Mass., July 01, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of two senior leaders, the Human Capital Management and Compensation Committee (the “Committee”) of Definitive Healthcare’s Board of Directors granted inducement awards. The Committee granted Jeannine Lombardi, Definitive Healthcare’s new Chief Human Resource Officer, an inducement award consisting of 421,349 time-based restricted stock units (“RSUs”), and Jonathan Paris, Definitive Healthcare’s new Chief Legal Officer, an inducement award consisting of 421,349 time-based RSUs, each effective July 1, 2025. Each of these awards was individually negotiated and was granted as an inducement material to Ms. Lombardi’s and Mr. Paris’s respective commencement of employment with Definitive Healthcare in accordance with Nasdaq Listing Rule 5635(c)(4).

Each of the awards is subject to the terms and conditions of Definitive Healthcare’s 2023 Inducement Plan and the terms and conditions of an applicable award agreement covering the grant.

Ms. Lombardi’s and Mr. Paris’s RSUs will vest as follows, subject to their continued employment through each such date: (i) 25% will vest on July 1, 2026; (ii) the remainder will vest in quarterly installments equal to 6.25% of the total RSUs over the subsequent 3 years, until fully vested.

About Definitive Healthcare

At Definitive Healthcare, our passion is to transform data, analytics, and expertise into healthcare commercial intelligence. We help clients uncover the right markets, opportunities, and people, so they can shape tomorrow’s healthcare industry. Our SaaS platform creates new paths to commercial success in the healthcare market, so companies can identify where to go next. Learn more at definitivehc.com.

Investor Contact:
Brian Denyeau
ICR for Definitive Healthcare
brian.denyeau@icrinc.com
646-277-1251

Media Contact:
Bethany Swackhamer
bswackhamer@definitivehc.com

FAQ

What inducement grants did Definitive Healthcare (DH) announce on July 1, 2025?

Definitive Healthcare granted 421,349 time-based RSUs each to Jeannine Lombardi (new CHRO) and Jonathan Paris (new CLO).

What is the vesting schedule for the DH RSU grants announced in July 2025?

The RSUs will vest 25% on July 1, 2026, with the remainder vesting in quarterly installments of 6.25% over the following 3 years.

Who are the new executives joining Definitive Healthcare (DH) in July 2025?

Jeannine Lombardi joined as Chief Human Resource Officer and Jonathan Paris as Chief Legal Officer.

Under which rule were the Definitive Healthcare RSU grants made?

The grants were made under Nasdaq Listing Rule 5635(c)(4) and Definitive Healthcare's 2023 Inducement Plan.